S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Become an Investor in Brooklyn Gin (Ad)pixel
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Invest in Brooklyn Gin: Hot craft spirits opportunity (Ad)pixel
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
NASDAQ:INGN

Inogen - INGN Stock Forecast, Price & News

$22.78
+0.42 (+1.88%)
(As of 01/26/2023 12:00 AM ET)
Add
Compare
Today's Range
$22.46
$23.30
50-Day Range
$19.14
$24.06
52-Week Range
$19.08
$36.30
Volume
56,085 shs
Average Volume
224,970 shs
Market Capitalization
$522.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.33

Inogen MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
28.8% Upside
$29.33 Price Target
Short Interest
Bearish
5.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.12
Upright™ Environmental Score
News Sentiment
0.49mentions of Inogen in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.88) to ($1.81) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Medical Sector

620th out of 1,048 stocks

Surgical Appliances & Supplies Industry

14th out of 23 stocks


INGN stock logo

About Inogen (NASDAQ:INGN) Stock

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Stock News Headlines

Inogen, Inc. (NASDAQ:INGN) Short Interest Up 15.4% in December
Inogen (NASDAQ:INGN) Stock Rating Lowered by William Blair
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
Become an Investor in Brooklyn Gin
Award winning super-premium craft gin and upcoming Brooklyn distillerypixel
Inogen (INGN) Q3 Earnings and Revenues Beat Estimates
Inogen Announces Third Quarter 2022 Financial Results
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates
See More Headlines
Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Company Calendar

Last Earnings
11/02/2022
Today
1/26/2023
Next Earnings (Confirmed)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INGN
Fax
N/A
Employees
1,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.33
High Stock Price Forecast
$36.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+28.8%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-6,330,000.00
Pretax Margin
-9.22%

Debt

Sales & Book Value

Annual Sales
$358 million
Cash Flow
$0.65 per share
Book Value
$16.29 per share

Miscellaneous

Free Float
22,648,000
Market Cap
$522.14 million
Optionable
Optionable
Beta
0.93

Key Executives

  • Mr. Nabil Shabshab (Age 58)
    CEO, Pres & Director
    Comp: $3.24M
  • Mr. Bart Sanford (Age 57)
    Exec. VP of Operations
    Comp: $558.22k
  • Dr. Stanislav Glezer M.D. (Age 50)
    MBA, Exec. VP & CTO
    Comp: $628.3k
  • Mr. George J. Parr (Age 52)
    Exec. VP & Chief Commercial Officer
    Comp: $799.95k
  • Ms. Kristin A. Caltrider (Age 55)
    Exec. VP, CFO & Treasurer
  • Ms. Agnes Lee
    Sr. VP of Investor Relations & Strategic Planning
  • Mr. Jason Somer (Age 55)
    Exec. VP, Gen. Counsel & Corp. Sec.
  • Ms. Jennifer Yi Boyer
    Exec. VP & Chief HR Officer
  • Mr. Matthew Pigeon
    Investor Relations Officer













INGN Stock - Frequently Asked Questions

Should I buy or sell Inogen stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" INGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INGN, but not buy additional shares or sell existing shares.
View INGN analyst ratings
or view top-rated stocks.

What is Inogen's stock price forecast for 2023?

3 Wall Street analysts have issued 12-month price targets for Inogen's shares. Their INGN share price forecasts range from $22.00 to $36.00. On average, they anticipate the company's share price to reach $29.33 in the next twelve months. This suggests a possible upside of 28.8% from the stock's current price.
View analysts price targets for INGN
or view top-rated stocks among Wall Street analysts.

How have INGN shares performed in 2023?

Inogen's stock was trading at $19.71 at the beginning of 2023. Since then, INGN stock has increased by 15.6% and is now trading at $22.78.
View the best growth stocks for 2023 here
.

When is Inogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our INGN earnings forecast
.

How can I listen to Inogen's earnings call?

Inogen will be holding an earnings conference call on Thursday, February 23rd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13735129".

How were Inogen's earnings last quarter?

Inogen, Inc. (NASDAQ:INGN) posted its quarterly earnings results on Wednesday, November, 2nd. The medical technology company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.23. The medical technology company earned $105.39 million during the quarter, compared to analyst estimates of $97.57 million. Inogen had a negative trailing twelve-month return on equity of 11.02% and a negative net margin of 13.69%.

What guidance has Inogen issued on next quarter's earnings?

Inogen issued an update on its fourth quarter 2022 earnings guidance on Tuesday, January, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $87.50 million-$88.50 million, compared to the consensus revenue estimate of $89.55 million.

What is Scott Wilkinson's approval rating as Inogen's CEO?

70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX).

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Who are Inogen's major shareholders?

Inogen's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.31%), Investment Management of Virginia LLC (0.12%), Yousif Capital Management LLC (0.06%), Comerica Bank (0.06%) and Strs Ohio (0.04%). Insiders that own company stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Holdings A/S Novo, Ray Benjamin M Anderson and Raymond Huggenberger.
View institutional ownership trends
.

How do I buy shares of Inogen?

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $22.78.

How much money does Inogen make?

Inogen (NASDAQ:INGN) has a market capitalization of $522.14 million and generates $358 million in revenue each year. The medical technology company earns $-6,330,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis.

How many employees does Inogen have?

The company employs 1,021 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The official website for the company is www.inogen.com. The medical technology company can be reached via phone at (805) 562-0500 or via email at mpigeon@inogen.net.

This page (NASDAQ:INGN) was last updated on 1/27/2023 by MarketBeat.com Staff